DOCSLIB.ORG

Arabidopsis IWS1 Interacts with Transcription Factor BES1 and Is Involved in Plant Steroid Hormone Brassinosteroid Regulated Gene Expression

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Arabidopsis IWS1 Interacts with Transcription Factor BES1 and Is Involved in Plant Steroid Hormone Brassinosteroid Regulated Gene Expression Arabidopsis IWS1 interacts with transcription factor BES1 and is involved in plant steroid hormone brassinosteroid regulated gene expression Lei Li, Huaxun Ye, Hongqing Guo, and Yanhai Yin1 Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA 50011 Edited by Mark Estelle, The University of California San Diego, La Jolla, CA, and approved January 08, 2010 (received for review August 13, 2009) Plant steroid hormones, brassinosteroids (BRs), regulate essential knowledge about the transcriptional mechanisms by which BES1 growth and developmental processes. BRs signal throughmembrane- and BZR1 regulate gene expression is still limited. localized receptor BRI1 and several other signaling components to IWS1/SPN1 protein was firstly identified in yeast (13, 14). It was regulate the BES1 and BZR1 family transcription factors, which in turn reported to be involved in postrecruitment of RNAPII-mediated control the expression of hundreds of target genes. However, knowl- transcription and required for the expression of several inducible edge about the transcriptional mechanisms by which BES1/BZR1 genes (14). It was also copurified with RNAPII and several tran- regulate gene expression is limited. By a forward genetic approach, scription elongation factors, including Spt6, Spt4/Spt5, and TFIIS we have discovered that Arabidopsis thaliana Interact-With-Spt6 (13, 15, 16). Recent studies indicated that the yeast IWS1/SPN1 (AtIWS1), an evolutionarily conservedproteinimplicatedinRNApoly- recruited Spt6 and the SWI/SNF chromatin remodeling complex merase II (RNAPII) postrecruitment and transcriptional elongation pro- during transcriptional activation (17). Human IWS1 has been cesses, is required for BR-induced gene expression. Loss-of-function shown to facilitate mRNA export and to coordinate Spt6 and the mutations in AtIWS1 lead to overall dwarfism in Arabidopsis, reduced histone methyltransferase HYBP/Setd2 to regulate histone mod- BR response, genome-wide decrease in BR-induced gene expression, ifications (18, 19). IWS1 appears to be essential, as depletion/ and hypersensitivity to a transcription elongation inhibitor. Moreover, reduction of IWS1 gene results in lethality in yeast (14) and sig- AtIWS1 interacts with BES1 both in vitro and in vivo. Chromatin immu- nificant inhibition of human cell proliferation in vitro (20). How- noprecipitation experiments demonstrated that the presence of ever, the biological function of IWS1/SPN1 and mechanism of its AtIWS1 is enriched in transcribed as well as promoter regions of the action remain largely elusive. target genes under BR-induced conditions. Our results suggest that In this study, we found that AtIWS1, the yeast and human AtIWS1 is recruited to target genes by BES1 to promote gene expres- counterparts of which are implicated in gene expression processes sion during transcription elongation process. Recent genomic studies after RNAPII recruitment (14, 17–19, 21), interacts with tran- have indicated that a large number of genes could be regulated at steps scription factor BES1 and is required for BR-induced gene after RNAPII recruitment; however, the mechanisms for such regula- expression. Our results therefore establish an important role for tion have not been well established. The study therefore not only AtIWS1 in plant steroid–induced gene expression and provide establishes an important role for AtIWS1 in plant steroid–induced gene insights into the functions of this conserved protein across eukar- expression but also suggests an exciting possibility that IWS1 protein yotes as well as into the mechanism of transcriptional regulation. can function as a target for pathway-specific activators, thereby pro- viding a unique mechanism for the control of gene expression. Results seb1 Suppresses bes1-D Phenotype and Has Reduced BR Response. In plant growth | transcription regulation | transcription elongation | RNA an attempt to identify BES1 downstream signaling components, polymerase II | Spt6 we screened for suppressors of bes1-D gain-of-function mutant. One of the suppressors, bes1-D seb1, was selected for further lant steroid hormones, brassinosteroids (BRs), regulate studies because of its strong suppression of the bes1-D phenotype Pdiverse plant growth and developmental processes such as cell (Fig. 1). seb1 is a single recessive mutation, as the F1 seedlings of elongation, vascular development, photomorphogenesis, repro- bes1-D seb1 and bes1-D cross displayed bes1-D phenotype and F2 duction, and stress responses (1, 2). Unlike animal steroid hor- segregated suppressors showed a 3:1 ratio. Whereas bes1-D mones that bind to nuclear receptors to directly regulate expression seedlings displayed excessive stem elongation, bes1-D seb1 of target genes, BRs function through membrane-localized recep- seedlings had reduced stem elongation (Fig. 1A). Unlike bes1-D, tor BRI1 and several other components to regulate the protein which was resistant to BRZ inhibition in hypocotyl elongation levels and activities of BES1 and BZR1 family transcription factors assays, the bes1-D seb1 double mutant restored BRZ sensitivity, (3–8), which have six members in Arabidopsis. Although knockout suggesting that this suppressor gene is required for the bes1-D of BES1 alone does not give obvious phenotype, knockdown of phenotype (Fig. 1B). BES1 and BZR1 by RNAi leads to a semidwarf phenotype, sug- We next cloned the SEB1 gene by map based cloning (Fig. gesting that this family of proteins function redundantly in BR S1A). The seb1 mutation was first narrowed down to a 60-kb signaling (9). BES1 and BZR1 have atypical basic helix–loop–helix region by a set of flanking markers. Five candidate genes in the (bHLH) DNA binding domain and bind to E-box (CANNTG) and/ interval were then sequenced. A “G” to “A” mutation in Ara- or BRRE (BR Response Element, CGTGT/CG) to regulate BR target gene expression (9, 10). In addition, BES1 interacts with other transcription factors such as BIM1 and AtMYB30 as well as Author contributions: L.L. and Y.Y. designed research; L.L. performed research; L.L. and H.Y. putative histone demethylases ELF6 and REF6 (9, 11, 12). Con- contributed new reagents/analytic tools; L.L., H.Y., and M.G. analyzed data; and L.L., M.G., sistent with the important roles of BES1 in mediating BR signaling, and Y.Y. wrote the paper. the gain-of-function mutant bes1-D, in which BES1 protein accu- The authors declare no conflict of interest. mulates to high level, displays constitutive BR response pheno- This article is a PNAS Direct Submission. types, including excessive cell elongation, resistance to the BR 1To whom correspondence should be addressed. E-mail: [email protected]. biosynthesis inhibitor brassinazole (BRZ), and increased expres- This article contains supporting information online at www.pnas.org/cgi/content/full/ sion of BR-induced genes (7). Despite the emerging findings, 0909198107/DCSupplemental. 3918–3923 | PNAS | February 23, 2010 | vol. 107 | no. 8 www.pnas.org/cgi/doi/10.1073/pnas.0909198107 Downloaded by guest on October 3, 2021 BR-Induced Gene Expression Is Decreased in seb1 Mutant. To understand the molecular basis for impaired BR response and growth phenotype of the seb1 mutant, we first tested the expres- sion of several known BR target genes using quantitative RT- PCR. The expression of all four genes tested were significantly reduced in the seb1 mutant and increased in the bes1-D mutant, especially under BL-induced conditions (Fig. 2A). To gain a global view of how many BR-regulated genes are affected in the mutants, we performed microarray analyses using WT, seb1, and bes1-D seedlings (all in En-2 background) with or without BL treatments. These experiments identified 3138 and 3824 differ- entially expressed genes in seb1 and bes1-D, respectively, com- pared with WT (Fig. S5). The substantial overlap (1437 genes) between AtIWS1- and BES1-regulated genes suggests that AtIWS1 plays important roles in the BR signaling pathway. To understand this further, we analyzed in greater depth the genes that were induced by BL and were reduced in seb1 mutant (Fig. 2 B and C). Of the 406 genes that were induced by BL, ≈70% were Fig. 1. seb1 Suppresses bes1-D phenotype and has reduced BR response. (A) up-regulated in bes1-D (Fig. 2C and Table S1). Comparison of the Two-week-old light-grown seedlings. (B) Hypocotyl elongation assay with 2- seb1 and WT gene expression profiles indicated that a large week-old light-grown seedlings in the absence or presence of 1000 nM BRZ. fraction of the BL-responsive genes were also regulated by (C) Two-week-old light-growing seedlings of Col-0, T-DNA insertion line AtIWS1: 31% (127/406) were reduced in seb1 in the presence of atiws1 (SALK_056238) in Col-0 background, En-2, and seb1 single mutant in BL, whereas 16% (66 / 406) were reduced in seb1 in the absence of En-2 background. (D) Hypocotyl elongation assays with 2-week-old light- B – grown seedlings (0 and 100 nM BL), or 5-day-old dark-growing seedlings (0 BL (Fig. 2 and Table S1 Table S3). Most of the BL-induced or 1,000 nM BRZ). A total of 15–20 seedlings were used for each line for each genes that were reduced in seb1 (59/66) were also included in the condition and the difference between mutants and wild-type were sig- 127 genes reduced in seb1 in the presence of BL (Fig. 2B). The nificant, as measured by Student’s t test (P < 0.05). same conclusion can be drawn from the gene clustering analysis with the 406 BR-induced genes (Fig. 2C). These genome-wide analyses revealed that AtIWS1 plays important roles in BL- bidopsis fi gene At1g32130 was identi ed, which created an early stop induced gene expression. codon in the middle of the gene (Fig. S1B). Expression of a genomic To further understand the reduced growth phenotype of seb1, clone of At1g32130 in the bes1-D seb1 mutant complemented the we examined genes implicated in cell elongation (Table 1).
Load more

Recommended publications
  • Regulation of SETD2 Stability Is Important for the Fidelity Of
    Bhattacharya and Workman Epigenetics & Chromatin (2020) 13:40 Epigenetics & Chromatin https://doi.org/10.1186/s13072-020-00362-8 RESEARCH Open Access Regulation of SETD2 stability is important for the fdelity of H3K36me3 deposition Saikat Bhattacharya and Jerry L. Workman* Abstract Background: The histone H3K36me3 mark regulates transcription elongation, pre-mRNA splicing, DNA methylation, and DNA damage repair. However, knowledge of the regulation of the enzyme SETD2, which deposits this function- ally important mark, is very limited. Results: Here, we show that the poorly characterized N-terminal region of SETD2 plays a determining role in regulat- ing the stability of SETD2. This stretch of 1–1403 amino acids contributes to the robust degradation of SETD2 by the proteasome. Besides, the SETD2 protein is aggregate prone and forms insoluble bodies in nuclei especially upon proteasome inhibition. Removal of the N-terminal segment results in the stabilization of SETD2 and leads to a marked increase in global H3K36me3 which, uncharacteristically, happens in a Pol II-independent manner. Conclusion: The functionally uncharacterized N-terminal segment of SETD2 regulates its half-life to maintain the requisite cellular amount of the protein. The absence of SETD2 proteolysis results in a Pol II-independent H3K36me3 deposition and protein aggregation. Keywords: Chromatin, Proteasome, Histone, Methylation, Aggregation Background In yeast, the SET domain-containing protein Set2 Te N-terminal tails of histones protrude from the nucle- (ySet2) is the sole H3K36 methyltransferase [10]. ySet2 osome and are hotspots for the occurrence of a variety interacts with the large subunit of the RNA polymerase II, of post-translational modifcations (PTMs) that play key Rpb1, through its SRI (Set2–Rpb1 Interaction) domain, roles in regulating epigenetic processes.
    [Show full text]
  • Multiple Cellular Proteins Interact with LEDGF/P75 Through a Conserved Unstructured Consensus Motif
    ARTICLE Received 19 Jan 2015 | Accepted 1 Jul 2015 | Published 6 Aug 2015 DOI: 10.1038/ncomms8968 Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif Petr Tesina1,2,3,*, Katerˇina Cˇerma´kova´4,*, Magdalena Horˇejsˇ´ı3, Katerˇina Procha´zkova´1, Milan Fa´bry3, Subhalakshmi Sharma4, Frauke Christ4, Jonas Demeulemeester4, Zeger Debyser4, Jan De Rijck4,**, Va´clav Veverka1,** & Pavlı´na Rˇeza´cˇova´1,3,** Lens epithelium-derived growth factor (LEDGF/p75) is an epigenetic reader and attractive therapeutic target involved in HIV integration and the development of mixed lineage leukaemia (MLL1) fusion-driven leukaemia. Besides HIV integrase and the MLL1-menin complex, LEDGF/p75 interacts with various cellular proteins via its integrase binding domain (IBD). Here we present structural characterization of IBD interactions with transcriptional repressor JPO2 and domesticated transposase PogZ, and show that the PogZ interaction is nearly identical to the interaction of LEDGF/p75 with MLL1. The interaction with the IBD is maintained by an intrinsically disordered IBD-binding motif (IBM) common to all known cellular partners of LEDGF/p75. In addition, based on IBM conservation, we identify and validate IWS1 as a novel LEDGF/p75 interaction partner. Our results also reveal how HIV integrase efficiently displaces cellular binding partners from LEDGF/p75. Finally, the similar binding modes of LEDGF/p75 interaction partners represent a new challenge for the development of selective interaction inhibitors. 1 Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i., Flemingovo nam. 2, 166 10 Prague, Czech Republic. 2 Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Vinicna 5, 128 44 Prague, Czech Republic.
    [Show full text]
  • Recognition of Cancer Mutations in Histone H3K36 by Epigenetic Writers and Readers Brianna J
    EPIGENETICS https://doi.org/10.1080/15592294.2018.1503491 REVIEW Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers Brianna J. Kleina, Krzysztof Krajewski b, Susana Restrepoa, Peter W. Lewis c, Brian D. Strahlb, and Tatiana G. Kutateladzea aDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA; bDepartment of Biochemistry & Biophysics, The University of North Carolina School of Medicine, Chapel Hill, NC, USA; cWisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA ABSTRACT ARTICLE HISTORY Histone posttranslational modifications control the organization and function of chromatin. In Received 30 May 2018 particular, methylation of lysine 36 in histone H3 (H3K36me) has been shown to mediate gene Revised 1 July 2018 transcription, DNA repair, cell cycle regulation, and pre-mRNA splicing. Notably, mutations at or Accepted 12 July 2018 near this residue have been causally linked to the development of several human cancers. These KEYWORDS observations have helped to illuminate the role of histones themselves in disease and to clarify Histone; H3K36M; cancer; the mechanisms by which they acquire oncogenic properties. This perspective focuses on recent PTM; methylation advances in discovery and characterization of histone H3 mutations that impact H3K36 methyla- tion. We also highlight findings that the common cancer-related substitution of H3K36 to methionine (H3K36M) disturbs functions of not only H3K36me-writing enzymes but also H3K36me-specific readers. The latter case suggests that the oncogenic effects could also be linked to the inability of readers to engage H3K36M. Introduction from yeast to humans and has been shown to have a variety of functions that range from the control Histone proteins are main components of the of gene transcription and DNA repair, to cell cycle nucleosome, the fundamental building block of regulation and nutrient stress response [8].
    [Show full text]
  • Loss of Function SETD2 Mutations in Poorly Differentiated Metastases
    cancers Article Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid 1, 1, 1 2 1 Valeria Pecce y , Antonella Verrienti y, Luana Abballe , Raffaella Carletti , Giorgio Grani , Rosa Falcone 1, Valeria Ramundo 1, Cosimo Durante 1, Cira Di Gioia 2 , Diego Russo 3 , Sebastiano Filetti 1 and Marialuisa Sponziello 1,* 1 Department of Translational and Precision Medicine, “Sapienza” University of Rome, 00161 Rome, Italy; [email protected] (V.P.); [email protected] (A.V.); [email protected] (L.A.); [email protected] (G.G.); [email protected] (R.F.); [email protected] (V.R.); [email protected] (C.D.); sebastiano.fi[email protected] (S.F.) 2 Department of Radiological, Oncological and Pathological Sciences, “Sapienza” University of Rome, 00161 Rome, Italy; raff[email protected] (R.C.); [email protected] (C.D.G.) 3 Department of Health Sciences, “Magna Graecia” University of Catanzaro, 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 23 June 2020; Accepted: 11 July 2020; Published: 14 July 2020 Abstract: Hürthle cell carcinomas (HCC) are rare differentiated thyroid cancers that display low avidity for radioactive iodine and respond poorly to kinase inhibitors. Here, using next-generation sequencing, we analyzed the mutational status of primary tissue and poorly differentiated metastatic tissue from two HCC patients. In both cases, metastatic tissues harbored a mutation of SETD2, each resulting in loss of the SRI and WW domains of SETD2, a methyltransferase that trimethylates H3K36 (H3K36me3) and also interacts with p53 to promote its stability.
    [Show full text]
  • SETD2 Mutations in Primary Central Nervous System Tumors Angela N
    Viaene et al. Acta Neuropathologica Communications (2018) 6:123 https://doi.org/10.1186/s40478-018-0623-0 RESEARCH Open Access SETD2 mutations in primary central nervous system tumors Angela N. Viaene1, Mariarita Santi1, Jason Rosenbaum2, Marilyn M. Li1, Lea F. Surrey1 and MacLean P. Nasrallah2,3* Abstract Mutations in SETD2 are found in many tumors, including central nervous system (CNS) tumors. Previous work has shown these mutations occur specifically in high grade gliomas of the cerebral hemispheres in pediatric and young adult patients. We investigated SETD2 mutations in a cohort of approximately 640 CNS tumors via next generation sequencing; 23 mutations were detected across 19 primary CNS tumors. Mutations were found in a wide variety of tumors and locations at a broad range of allele frequencies. SETD2 mutations were seen in both low and high grade gliomas as well as non-glial tumors, and occurred in patients greater than 55 years of age, in addition to pediatric and young adult patients. High grade gliomas at first occurrence demonstrated either frameshift/truncating mutations or point mutations at high allele frequencies, whereas recurrent high grade gliomas frequently harbored subclones with point mutations in SETD2 at lower allele frequencies in the setting of higher mutational burdens. Comparison with the TCGA dataset demonstrated consistent findings. Finally, immunohistochemistry showed decreased staining for H3K36me3 in our cohort of SETD2 mutant tumors compared to wildtype controls. Our data further describe the spectrum of tumors in which SETD2 mutations are found and provide a context for interpretation of these mutations in the clinical setting. Keywords: SETD2, Histone, Brain tumor, Glioma, Epigenetics, H3K36me3 Introduction (H3K36me3) in humans.
    [Show full text]
  • The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
    The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs.
    [Show full text]
  • Cancer-Driving H3G34V/R/D Mutations Block H3K36 Methylation and H3k36me3–Mutsα Interaction
    Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3–MutSα interaction Jun Fanga,b,1, Yaping Huanga,b,1, Guogen Maoc,1, Shuang Yanga,b, Gadi Rennertd, Liya Gue, Haitao Lia,b, and Guo-Min Lic,e,2 aTsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100080, China; bDepartment of Basic Medical Sciences, Tsinghua University, Beijing 100080, China; cDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506; dDepartment of Community Medicine and Epidemiology, Carmel Medical Center, Clalit National Israeli Cancer Control Center, Haifa 3436212, Israel; and eDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390 Edited by Paul Modrich, HHMI and Duke University Medical Center, Durham, NC, and approved August 9, 2018 (received for review April 12, 2018) Somatic mutations on glycine 34 of histone H3 (H3G34) cause cancers; however, how H3G34 mutations induce tumorigenesis pediatric cancers, but the underlying oncogenic mechanism re- is unknown. mains unknown. We demonstrate that substituting H3G34 with Since H3G34 is in close proximity to H3K36, we hypothesize that arginine, valine, or aspartate (H3G34R/V/D), which converts the a large side chain created by G34D, G34R, and G34V mutations in non-side chain glycine to a large side chain-containing residue, H3 blocks the interaction between SETD2 and the H3 tail, inhibiting blocks H3 lysine 36 (H3K36) dimethylation and trimethylation by H3K36 trimethylation. Similarly, the large side chains may also in- histone methyltransferases, including SETD2, an H3K36-specific hibit the H3K36me3–MutSα interaction. We tested these hypotheses trimethyltransferase. Our structural analysis reveals that the H3 and found evidence of their validity.
    [Show full text]
  • A Collection of Pre-Mrna Splicing Mutants in Arabidopsis Thaliana
    G3: Genes|Genomes|Genetics Early Online, published on April 7, 2020 as doi:10.1534/g3.119.400998 1 1 A collection of pre-mRNA splicing mutants in Arabidopsis thaliana 2 3 4 Tatsuo Kanno1,a, Peter Venhuizen2,a, Ming-Tsung Wu3, Phebe Chiou1, Chia-Liang Chang1, 5 Maria Kalyna2,c, Antonius J.M. Matzke1,c and Marjori Matzke1,c 6 7 1Institute of Plant and Microbial Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang 8 District, Taipei, 11529 Taiwan 9 10 2Department of Applied Genetics and Cell Biology, University of Natural Resources and Life 11 Sciences - BOKU, Muthgasse 18, 1190 Vienna, Austria 12 13 3Department of Plant Sciences, University of Cambridge, Downing Street, CB2 3EA Cambridge, 14 UK 15 16 athese authors should be regarded as joint first authors 17 18 19 cCorresponding authors: 20 Antonius J.M. Matzke ([email protected]) 21 Tel: +886-2787-1135 22 Marjori Matzke ([email protected]) 23 Tel: +886-2787-1135 24 Maria Kalyna ([email protected]) 25 Tel: +43-1-47654-94112 26 27 28 29 30 31 32 © The Author(s) 2020. Published by the Genetics Society of America. 2 33 34 Running title: Arabidopsis pre-mRNA splicing mutants 35 36 Key words: Arabidopsis thaliana, CBP80. miRNAs, mutant screen, pre-mRNA splicing 37 38 39 40 Corresponding authors: 41 Antonius J.M. Matzke ([email protected]), Institute of Plant and Microbial 42 Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang District, Taipei, 11529 Taiwan 43 Tel: +886-2787-1135 44 45 Marjori Matzke ([email protected]), Institute of Plant and Microbial Biology, 46 Academia Sinica, 128, Sec.
    [Show full text]
  • IWS1 Antibody A
    Revision 1 C 0 2 - t IWS1 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 1 8 Web: [email protected] 6 www.cellsignal.com 5 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP, IF-IC H M R Endogenous 140 Rabbit Q96ST2 55677 Product Usage Information Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:50 Immunofluorescence (Immunocytochemistry) 1:200 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity IWS1 Antibody detects endogenous levels of total IWS1 protein. Species Reactivity: Human, Mouse, Rat Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human IWS1 protein. Antibodies are purified by protein A and peptide affinity chromatography. Background Various steps in gene expression, such as mRNA processing, surveillance, export, and synthesis are coupled to transcription elongation (1,2). The C-terminal domain (CTD) of the large subunit of RNA polymerase II plays an important role in the integration of these different steps (1,2). IWS1 interacts with Spt6, a CTD-binding transcription elongation factor and H3 chaperone (1,2). IWS1 also recruits another CTD-binding protein, HYPB/Setd2 histone methyltransferase, to the RNA polymerase II complex for elongation-coupled H3K36 trimethylation (2). Thus, IWS1 links Spt6 and HYPB/Setd2 in a large complex and regulates mRNA synthesis and histone methylation at the co- transcriptional level (2).
    [Show full text]
  • Dynamics of Transcription-Dependent H3k36me3 Marking by the SETD2:IWS1:SPT6 Ternary Complex
    bioRxiv preprint doi: https://doi.org/10.1101/636084; this version posted May 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamics of transcription-dependent H3K36me3 marking by the SETD2:IWS1:SPT6 ternary complex Katerina Cermakova1, Eric A. Smith1, Vaclav Veverka2, H. Courtney Hodges1,3,4,* 1 Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA 2 Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic 3 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA 4 Department of Bioengineering, Rice University, Houston, TX, 77005, USA * Lead contact; Correspondence to: [email protected] Abstract The genome-wide distribution of H3K36me3 is maintained SETD2 contributes to gene expression by marking gene through various mechanisms. In human cells, H3K36 is bodies with H3K36me3, which is thought to assist in the mono- and di-methylated by eight distinct histone concentration of transcription machinery at the small portion methyltransferases; however, the predominant writer of the of the coding genome. Despite extensive genome-wide data trimethyl mark on H3K36 is SETD21,11,12. Interestingly, revealing the precise localization of H3K36me3 over gene SETD2 is a major tumor suppressor in clear cell renal cell bodies, the physical basis for the accumulation, carcinoma13, breast cancer14, bladder cancer15, and acute maintenance, and sharp borders of H3K36me3 over these lymphoblastic leukemias16–18. In these settings, mutations sites remains rudimentary.
    [Show full text]
  • A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer.
    [Show full text]
  • Structure/Function Analysis of Recurrent Mutations in SETD2
    crossmark THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 40, pp. 21283–21295, September 30, 2016 © 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation* Received for publication, May 21, 2016, and in revised form, August 10, 2016 Published, JBC Papers in Press, August 15, 2016, DOI 10.1074/jbc.M116.739375 Kathryn E. Hacker‡§1, Catherine C. Fahey‡§1, Stephen A. Shinsky§¶1, Yun-Chen J. Chiang§1, Julia V. DiFiore‡¶1, Deepak Kumar Jha§¶, Andy H. Voʈ, Jordan A. Shavitʈ, Ian J. Davis‡§**, Brian D. Strahl‡§¶2, and W. Kimryn Rathmell‡§‡‡3 From the ‡Department of Genetics, Curriculum in Genetics and Molecular Biology, the §Lineberger Comprehensive Cancer Center, and the ¶Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, the ʈDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan 48109, the **Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27514, and the ‡‡Division of Hematology and Oncology, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232 The yeast Set2 histone methyltransferase is a critical enzyme Cancer is increasingly characterized by alterations in chro- that plays a number of key roles in gene transcription and DNA matin-modifying enzymes (1). SETD2, a non-redundant his- repair. Recently, the human homologue, SETD2, was found to be tone H3 lysine 36 (H3K36)4 methyltransferase (2), has been recurrently mutated in a significant percentage of renal cell carci- found to be mutated in a growing list of tumor types, most nomas, raising the possibility that the activity of SETD2 is tumor- notably in clear cell renal cell carcinoma (ccRCC) (1, 3, 4), but suppressive.
    [Show full text]